Dual targeted therapy shows promise in previously treated advanced kidney cancer patients
Results from a trial led by researchers from The University of Texas MD Anderson Cancer Center showed that a targeted therapy combination improved outcomes for patients with metastatic clear-cell renal carcinoma (ccRCC)—a ...
Oct 20, 2025
0
19









